BIOMAT Database Logo BIOMAT Database Logo

Radioiodine therapy of euthyroid multinodular goitres. 2002

Jeroen M B Manders, and Frans H M Corstens
University Medical Center Nijmegen, 565 Department of Nuclear Medicine, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands. j.manders@nucmed.umcn.nl

Euthyroid multinodular goitre is caused by excessive replication of thyroid epithelial cells, due to various stimuli. With time there is a gradual increase in size and in nodularity. The clinical manifestations arise solely from thyroid enlargement. Treatment of euthyroid multinodular goitre is indicated only when thyroid enlargement causes symptoms of obstruction, such as dysphagia and dyspnoea. Treatment options are radioiodine (iodine-131), surgery and TSH suppression therapy. In this review we compare these treatment modalities. In our opinion, radioiodine is the treatment of choice in elderly patients, in patients in whom surgery is contra-indicated and in patients who are unwilling to undergo surgery. The life-time risk of fatal and non-fatal cancer due to radioiodine is negligible in patients over 65 years of age, compared with the life-time risk of fatal cancer in the non-exposed population.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009381 Neoplasms, Radiation-Induced Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation. Radiation-Induced Cancer,Cancer, Radiation-Induced,Radiation-Induced Neoplasms,Cancer, Radiation Induced,Cancers, Radiation-Induced,Neoplasm, Radiation-Induced,Neoplasms, Radiation Induced,Radiation Induced Cancer,Radiation Induced Neoplasms,Radiation-Induced Cancers,Radiation-Induced Neoplasm
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002231 Carbimazole An imidazole antithyroid agent. Carbimazole is metabolized to METHIMAZOLE, which is responsible for the antithyroid activity. Carbimazole Henning,Neo Tomizol,Neo-Mercazole,Neo-Thyreostat,Neomercazole
D003952 Diagnostic Imaging Any visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. It includes measuring physiologic and metabolic responses to physical and chemical stimuli, as well as ultramicroscopy. Imaging, Diagnostic,Imaging, Medical,Medical Imaging
D005260 Female Females

Related Publications

Jeroen M B Manders, and Frans H M Corstens
Outpatient management of patients with large multinodular goitres treated with fractionated radioiodine.
December 1997, European journal of nuclear medicine,
Jeroen M B Manders, and Frans H M Corstens
Graves' disease and thyroid associated ophthalmopathy following radioiodine therapy in euthyroid multinodular goiter.
May 2008, Thyroid : official journal of the American Thyroid Association,
Jeroen M B Manders, and Frans H M Corstens
Radioiodine - an attractive alternative to surgery in large non-toxic multinodular goitres.
January 2009, Nuclear medicine review. Central & Eastern Europe,
Jeroen M B Manders, and Frans H M Corstens
Radioiodine therapy for multinodular goiter.
June 2008, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion,
Jeroen M B Manders, and Frans H M Corstens
[Radioiodine therapy in multinodular goiters].
May 2007, Medicina clinica,
Jeroen M B Manders, and Frans H M Corstens
Radioiodine therapy for multinodular toxic goiter.
June 1999, Archives of internal medicine,
Jeroen M B Manders, and Frans H M Corstens
Radioiodine therapy for thyroid volume reduction of large goitres.
June 2009, Nuclear medicine communications,
Jeroen M B Manders, and Frans H M Corstens
Radioiodine therapy of non-toxic multinodular goitre.
December 1994, Clinical endocrinology,
Jeroen M B Manders, and Frans H M Corstens
[RADIOIODINE THERAPY FOR REDUCING EUTHYROID GOITER].
January 1964, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
Jeroen M B Manders, and Frans H M Corstens
Risk factors for malignancy in multinodular goitres.
February 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Copied contents to your clipboard!